What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update.

Dale J Langford,Ralf Baron,Robert R Edwards,Jennifer S Gewandter,Ian Gilron,Robert Griffin,Peter R Kamerman,Nathaniel P Katz,Michael P McDermott,Andrew S C Rice,Dennis C Turk,Jan Vollert,Robert H Dworkin

Pain（2023）

引用 1|浏览13

暂无评分

摘要

In Brief Updated IMMPACT recommendations suggest minimum baseline pain intensity remain ≥4 of 10 for phase 2 and 3 clinical trials of chronic pain treatments.

查看译文

关键词

entry pain intensity criteria,chronic pain,clinical trials

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要